Neuropsychological assessment in vascular cognitive impairment: A call to lay the quest for the best test to rest.
作者信息
Biessels Geert Jan
机构信息
Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.
出版信息
Cereb Circ Cogn Behav. 2024 Mar 23;6:100219. doi: 10.1016/j.cccb.2024.100219. eCollection 2024.
Abstract
摘要
相似文献
1
Neuropsychological assessment in vascular cognitive impairment: A call to lay the quest for the best test to rest.血管性认知障碍的神经心理学评估：呼吁停止寻找最佳测试的探索。
Cereb Circ Cogn Behav. 2024 Mar 23;6:100219. doi: 10.1016/j.cccb.2024.100219. eCollection 2024.
2
Neuropsychological assessment and cerebral vascular disease: the new standards.神经心理学评估与脑血管病：新标准。
Rev Neurol (Paris). 2013 Oct;169(10):779-85. doi: 10.1016/j.neurol.2013.07.009. Epub 2013 Aug 30.
3
The pattern of neuropsychological deficits in Vascular Cognitive Impairment-No Dementia (Vascular CIND).血管性认知障碍无痴呆（Vascular CIND）的神经心理学缺陷模式。
Clin Neuropsychol. 2004 Feb;18(1):41-9. doi: 10.1080/13854040490507145.
4
Developing a Brief Neuropsychological Battery for Early Diagnosis of Cognitive Impairment.开发一种用于早期认知障碍诊断的简短神经心理学测试组合。
J Am Med Dir Assoc. 2019 Aug;20(8):1054.e11-1054.e20. doi: 10.1016/j.jamda.2019.02.028. Epub 2019 Apr 13.
5
Diagnosis of vascular cognitive impairment and its main categories.血管性认知障碍及其主要类型的诊断。
Neurologia. 2015 May;30(4):223-39. doi: 10.1016/j.nrl.2011.12.014. Epub 2012 Jun 26.
6
MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke.MoCA、ACE-R 和 MMSE 与 NINDS-CSN 血管性认知障碍协调标准神经心理学成套测验在 TIA 和卒中后的比较。
Stroke. 2012 Feb;43(2):464-9. doi: 10.1161/STROKEAHA.111.633586. Epub 2011 Dec 8.
7
Cognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessment.中风诊断后的认知障碍和记忆功能障碍：中风后记忆评估。
Neuropsychiatr Dis Treat. 2014 Sep 9;10:1677-91. doi: 10.2147/NDT.S67184. eCollection 2014.
8
Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke.中风后轻度血管性认知障碍和痴呆的神经心理学特征
Int J Geriatr Psychiatry. 2004 Nov;19(11):1053-7. doi: 10.1002/gps.1209.
9
Neuropsychological profiles of vascular disease and risk of dementia: implications for defining vascular cognitive impairment no dementia (VCI-ND).血管性疾病的神经心理学特征与痴呆风险：对定义血管性认知障碍但非痴呆（VCI-ND）的启示。
Age Ageing. 2017 Sep 1;46(5):755-760. doi: 10.1093/ageing/afx016.
10
Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study.MRI 血管性脑损伤标志物与卒中、轻度认知障碍、痴呆和死亡的相关性：弗雷明汉后代研究。
Stroke. 2010 Apr;41(4):600-6. doi: 10.1161/STROKEAHA.109.570044. Epub 2010 Feb 18.
引用本文的文献
1
Editorial. : The journal at age 5.社论：该期刊创刊五周年
Cereb Circ Cogn Behav. 2024 Sep 7;7:100368. doi: 10.1016/j.cccb.2024.100368. eCollection 2024.
本文引用的文献
1
When the central integrator disintegrates: A review of the role of the thalamus in cognition and dementia.当中央整合器瓦解时：丘脑在认知和痴呆中的作用综述。
Alzheimers Dement. 2024 Mar;20(3):2209-2222. doi: 10.1002/alz.13563. Epub 2023 Dec 2.
2
The effects of CNS atrophy and ICVD on tests of executive function and functional status are mediated by intelligence.中枢神经系统萎缩和缺血性脑血管病对执行功能测试及功能状态的影响是由智力介导的。
Cereb Circ Cogn Behav. 2023 Sep 15;5:100184. doi: 10.1016/j.cccb.2023.100184. eCollection 2023.
3
Intelligence, cognition, and major neurocognitive disorders: From constructs to measures.智力、认知与主要神经认知障碍：从概念到测量方法
Cereb Circ Cogn Behav. 2023 Sep 15;5:100185. doi: 10.1016/j.cccb.2023.100185. eCollection 2023.
4
Neuroimaging standards for research into small vessel disease-advances since 2013.神经影像学在小血管疾病研究中的标准——2013 年以来的进展。
Lancet Neurol. 2023 Jul;22(7):602-618. doi: 10.1016/S1474-4422(23)00131-X. Epub 2023 May 23.
5
Strategic white matter hyperintensity locations for cognitive impairment: A multicenter lesion-symptom mapping study in 3525 memory clinic patients.认知障碍的策略性脑白质高信号位置：3525 例记忆门诊患者的多中心病变-症状映射研究。
Alzheimers Dement. 2023 Jun;19(6):2420-2432. doi: 10.1002/alz.12827. Epub 2022 Dec 12.
6
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
7
Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE): A Review.脑小血管病临床试验框架（FINESSE）：综述。
JAMA Neurol. 2022 Nov 1;79(11):1187-1198. doi: 10.1001/jamaneurol.2022.2262.
8
Diagnosing vascular cognitive impairment: Current challenges and future perspectives.诊断血管性认知障碍：当前的挑战与未来展望。
Int J Stroke. 2023 Jan;18(1):36-43. doi: 10.1177/17474930211073387. Epub 2022 Jan 30.
9
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.用于阿尔茨海默病的血液生物标志物：迈向临床应用
Lancet Neurol. 2022 Jan;21(1):66-77. doi: 10.1016/S1474-4422(21)00361-6. Epub 2021 Nov 24.
10
The need to show minimum clinically important differences in Alzheimer's disease trials.在阿尔茨海默病临床试验中需要显示最小临床重要差异。
Lancet Psychiatry. 2021 Nov;8(11):1013-1016. doi: 10.1016/S2215-0366(21)00197-8. Epub 2021 Jun 1.
Zotero 插件